نتایج جستجو برای: botulinum toxin type a

تعداد نتایج: 13701766  

Journal: :Internal medicine 2016
Akio Kikuchi Atsushi Takeda Naoto Sugeno Emiko Miura Kazuhiro Kato Takafumi Hasegawa Toru Baba Masatoshi Konno Ryuji Oshima Shoichi Watanuki Kotaro Hiraoka Manabu Tashiro Masashi Aoki

We occasionally observe long-term remission of cervical dystonia after several botulinum toxin treatments. However, botulinum toxin transiently acts on neuromuscular junctions. We herein report that a cervical dystonia patient with spinocerebellar ataxia type 1 could have long-term remission as a result of the depression of hypermetabolism in the bilateral putamen and primary sensorimotor corte...

Journal: :Chemical communications 2008
Katerina Capková Mark S Hixon Laura A McAllister Kim D Janda

The development of a sensitive, yet reliable assay for the analysis of botulinum neurotoxin A (BoNT/A) inhibitors is described; using this assay a new protease inhibitor was characterized and found to be one of the most potent inhibitors reported to date.

Journal: :Infection and immunity 1986
L L Simpson

4-Aminopyridine and 3,4-diaminopyridine were evaluated for their abilities to delay the onset of paralysis due to botulinum neurotoxin types A, B, and E. Experiments were done on phrenic nerve-hemidiaphragm preparations excised from mice. At a concentration that produced an enhancement in muscle twitch amplitude, 4-aminopyridine and 3,4-diaminopyridine delayed the onset of paralysis due to botu...

Journal: :BMJ 2001
M Naumann N J Lowe

OBJECTIVES To evaluate the safety and efficacy of botulinum toxin type A in the treatment of bilateral primary axillary hyperhidrosis. DESIGN Multicentre, randomised, parallel group, placebo controlled trial. SETTING 17 dermatology and neurology clinics in Belgium, Germany, Switzerland, and the United Kingdom. PARTICIPANTS Patients aged 18-75 years with bilateral primary axillary hyperhid...

Journal: :Zhurnal mikrobiologii, epidemiologii, i immunobiologii 1964
T I BULATOVA

Journal: :Revista Headache Medicine 2022

Chronic migraine is an important cause of functional disability and quality life deficits, affecting 12% the world population. Therefore, more treatment alternatives that promote better pain control are needed. So, botulinum toxin type A presents itself as a therapeutic option for this purpose. This integrative review aimed to analyze functionality PREEMPT protocol applied chronic migraine, ana...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید